associate professor anthony j gill

Professor Gill teaches Surgical Pathology at the University of Sydney, the same institution in which he graduated in medicine in 1997. After graduating, he went on to complete his speciality training in surgical pathology (FRCPA) in 2005.

Currently, Professor Gill is a senior staff specialist in diagnostic pathology at the Royal North Shore Hospital, yet still lends a lot of time to medical research at the Garvan Institute of Medical Research and the University of Sydney.

He is the current chairman of the Australia Pancreatic Cancer Genome Initiative and in 2018, Professor Anthony Gill was honoured in the Queen’s Birthday list. For his significant service to medical research in the field of surgical pathology as an academic, author, adviser and mentor, he was appointed a Member of the Order of Australia (AM).


Research Interests

Prof Gill is a surgical pathologist, his research focuses on hereditary cancer syndromes, endocrine pathology and gastrointestinal pathology with a special emphasis on pancreaticobiliary pathology.

His research has concentrated on translating advances made in the understanding of cancer at the basic science or molecular level into diagnostic tests which can be applied in the routine surgical pathology laboratory on patient biopsy specimens.

Project Grants

“From mice to men: biomarker-driven classification of pancreatic cancer to define the gemcitabine/nab-paclitaxel responsive molecular subtype”

Cancer Australia Project Grant 2016

The Australian Pancreatic Cancer Genome Initiative: Biospecimen Core Resource

The Avner Pancreatic Cancer Foundation 2016

“Hereditary endocrine cancer: A model based on phaeochromocytoma-paraganglioma syndromes”

NHMRC Project Grant 2016

“NABNEC: A Randomised Phase II Study Of Nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas”

NHMRC Project Grant 2016

The further expansion, maintenance and deployment of a tissue of paraffin block containing cancers to mirror and expand frozen tissue bank assets”

Cancer Institute NSW Research Infrastructure Grant 2015

The Sydney 1000 Cancer Project – Stage 1 Gastrointestinal Cancers Immunophenotyping Study

University of Sydney SPARC implementation program 2015

Therapeutic targeting of cell cycle checkpoint aberrations in pancreatic cancer: personalised medicine in action”

NHMRC Project Grant

NBCF Repository of Patient Matched Primary Breast Tumours and Metastasis

National Breast Cancer Foundation 2014

Northern Translational Cancer Research Centre

Cancer Institute NSW 2014

“From functional genomics to precision medicine: The therapeutic potential of targeting ROCK signalling in pancreatic cancer”

Cancer Australia Project Grant 2013

“Establishing a Patient-Derived First Generation Tumour Xenograft Model: A Promising Tool for Rapid Guidance of Chemotherapeutic Responsiveness in Patients with Colorectal Liver Metastases”

Royal North Shore Staff Specialist Trust Fund 2013

Monoubiquitinated histone H2B – marking key pathways in ovarian cancer

Cancer Australia 2013

MALDI MS Imaging for Cancer Biomarker Discovery in the Northern Translational Cancer Research Unit

Cancer Institute NSW Research Infrastructure Grant 2012

“The creation of a readily accessible and clinically annotated tissue bank of paraffin blocks containing tumour to mirror and expand frozen tissue already collected by the Kolling Tumour Banks”

Cancer Institute NSW Research Infrastructure Grant 2012

“MALDI-TOF/TOF mass spectrometer, with associated Biomarker Identification and MALDI-Imaging solutions”

University of Sydney Cancer Research Fund Research Infrastructure Grant 2012

Targeting KCa3.1 in diabetic nephropathy

NHMCR Project Grant 2012

Chief Investigator D Translational Cancer Research Unit for Royal North Shore Hospital

Cancer Institute NSW 2011

Chief Investigator G Genotype Guided Cancer Therapy (Genomic Theranostics)

Cancer Council NSW 2011

“New opportunities for the study of ovarian cancer through characterization of mouse models”

Cancer Council NSW 2011

Trust fund support for research position

Pacific Laboratory Medicine Services 2011

Trust fund support for research position

Pacific Laboratory Medicine Services 2010

Trust fund support for research position

Pacific Laboratory Medicine Services 2009

“Research into Surgical Pathology”

Royal North Shore Hospital Cancer Key Area Grant 2009

“Testing the gonadotropin theory of ovarian surface epithelial carcinoma development in Brca1-deficient mice”

Northern Sydney Local Health District 2008

“Ovarian surface epithelial carcinoma modeling in Brca1-null mice mediated by Sleeping Beauty insertional mutagenesis”

Cure Cancer Australia Foundation 2008

Year Award Institution
1994 The Graham Couplan Prize The University of Sydney
1994 Fagan Memorial Prize for Surgery The University of Sydney
1994 NCS Medicine Prize for Medicine  
1995 The Department of Health Scholarship The Department of Health
1995 Medical Board Prize Australian National University
1995 The Campbell Kordick Memorial Prize The University of Sydney
1996 The Harry J Clayton Memorial Prize The University of Sydney
1996 The Hinder Memorial Prize The University of Sydney
1996 The Royal North Shore Medal Royal North Shore Hospital
2010 Innovative Teaching Award Royal North Shore Hospital
2011 The Benjamin Castleman Award United States and Canadian Academy of Pathology
2012 NSW Cancer Institute Wildfire Award Cancer Institute NSW
2013 Most Outstanding Teacher Award Royal North Shore Hospital
2013 NSW Premier’s Award for Excellence in Translational Cancer Research Cancer Institute NSW
2014 The Sir Zelman Cowen Universities Prize for discovery in Medical Research The University of Sydney
2014 Northern Clinical School Students Choice award for best lecturer The University of Sydney
2015 NSW Cancer Institute Wildfire Award Cancer Institute NSW
2017 Ramzi Cotran Young Investigator Award United States and Canadian Academy of Pathology
2017 Vincent McGovern Medal Australian division of The International Academy of Pathology
2018 Member of the Order The Order of Australia

Nahm, C., Brown, K., Townend, P., Colvin, E., Howell, V., Gill, A., Connor, S., Samra, J., Mittal, A. (2018). Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula. HPB, 20(5), 432-440. [More Information]

Wong, E., Oh, L., Andrici, J., McCluskey, P., Smith, J., Gill, A. (2018). Author reply. Internal Medicine Journal, 48(5), 608. [More Information]

Chou, A., Kim, Y., Samra, J., Pajic, M., Gill, A. (2018). BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma. Pathology, 50(3), 345-348. [More Information]

Townend, P., de Reuver, P., Chua, T., Mittal, A., Clark, S., Pavlakis, N., Gill, A., Samra, J. (2018). Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data. ANZ Journal of Surgery, 88(3), E167-E172. [More Information]

Gifford, G., Gabrielli, S., Gill, A., Greenwood, M., Wong, K., Best, G., Nevell, D., Mcilroy, K., Kliman, D., Ilmay-Gillespie, L., Stevenson, W., et al (2018). Lymphoma cell-of�origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts. British Journal of Haematology, 181(2), 272-275. [More Information]

Jayakody, S., Reagh, J., Bullock, M., Aniss, A., Clifton-Bligh, R., Learoyd, D., Robinson, B., Delbridge, L., Sidhu, S., Gill, A., Sywak, M. (2018). Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease. World Journal of Surgery, 42(5), 1432-1439. [More Information]

Gill, P., Chua, T., Huang, Y., Mehta, S., Mittal, A., Gill, A., Samra, J. (2018). Pancreatoduodenectomy and the risk of complications from perioperative fluid administration. ANZ Journal of Surgery, 88(4), E318-E323. [More Information]

Turchini, J., Cheung, V., Tischler, A., De Krijger, R., Gill, A. (2018). Pathology and genetics of phaeochromocytoma and paraganglioma. Histopathology, 72(1), 97-105. [More Information]

Foo, E., Turner, R., Wang, K., Aniss, A., Gill, A., Sidhu, S., Clifton-Bligh, R., Sywak, M. (2018). Predicting malignancy in adrenal incidentaloma and evaluation of a novel risk stratification algorithm. ANZ Journal of Surgery, 88(3), E173-E177. [More Information]

Gill, A. (2018). Succinate dehydrogenase (SDH)-deficient neoplasia. Histopathology, 72(1), 106-116. [More Information]

Dwight, T., Flynn, A., Amarasinghe, K., Benn, D., Lupat, R., Li, J., Cameron, D., Hogg, A., Balachander, S., Candiloro, I., Robinson, B., Gill, A., Clifton-Bligh, R., et al (2018). TERT structural rearrangements in metastatic pheochromocytomas. Endocrine-Related Cancer, 25(1), 1-9. [More Information]

Chou, A., Toon, C., Clarkson, A., Sheen, A., Sioson, L., Gill, A. (2018). The epithelioid, BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma. Histopathology, 72(3), 509-515. [More Information]

Bettison, T., Nahm, C., Gill, A., Mittal, A., Malhi, G., Samra, J. (2018). Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer: A Systematic Review. Pancreas, 47(4), 376-381. [More Information]

Oh, L., Wong, E., Gill, A., McCluskey, P., Smith, J. (2018). Value of temporal artery biopsy length in diagnosing giant cell arteritis. ANZ Journal of Surgery, 88(3), 191-195. [More Information]

Elston, M., Sehgal, S., Dray, M., Phillips, E., Conaglen, J., Clifton-Bligh, R., Gill, A. (2017). A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation. The Journal of Clinical Endocrinology and Metabolism, 102(5), 1447-1450. [More Information]

Barazeghi, E., Gill, A., Sidhu, S., Norlen, O., Dina, R., Palazzo, F., Hellman, P., Stalberg, P., Westin, G. (2017). A role for TET2 in parathyroid carcinoma. Endocrine-Related Cancer, 24(7), 329-338. [More Information]

Chandrasegaram, M., Gill, A., Samra, J., Price, T., Chen, J., Fawcett, J., Merrett, N. (2017). Ampullary cancer of intestinal origin and duodenal cancer – A logical clinical and therapeutic subgroup in periampullary cancer. World Journal of Gastrointestinal Oncology, 9(10), 407-415. [More Information]

Dwight, T., Na, U., Kim, E., Zhu, Y., Richardson, A., Robinson, B., Tucker, K., Gill, A., Benn, D., Clifton-Bligh, R., et al (2017). Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma. BMC Cancer, 17(1), 1-12. [More Information]

Kulkarni, A., Gundara, J., Gill, A., Hugh, T., Samra, J. (2017). Cholangiocarcinoma following external beam radiotherapy: A report of two cases. Oncology Letters, 14(1), 423-426. [More Information]

Stephenson, D., Nahm, C., Chua, T., Gill, A., Mittal, A., De Reuver, P., Samra, J. (2017). Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: A systematic review and meta-analysis. Oncotarget, 8(63), 107223-107236. [More Information]

Schlichtemeier, S., Logaraj, A., Gill, A., Engel, A. (2017). Colorectal cancer resection in the Australian nonagenarian patient. Colorectal Disease, 19(3), 243-250. [More Information]

Cole, A., Zhu, Y., Dwight, T., Yu, B., Dickson, K., Gard, G., Maidens, J., Valmadre, S., Gill, A., Clifton-Bligh, R., Marsh, D. (2017). Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency. Scientific Data, 4, 1-8. [More Information]

Flynn, A., Dwight, T., Benn, D., Deb, S., Colebatch, A., Fox, S., Harris, J., Duncan, E., Robinson, B., Hogg, A., Gill, A., Clifton-Bligh, R., et al (2017). Cousins not twins: intratumoral and intertumoral heterogeneity in syndromic neuroendocrine tumours. Journal of Pathology, 242(3), 273-283. [More Information]

Tang, C., Lindsay, J., Gill, A., Kerridge, I. (2017). Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome. Clinical Lymphoma, Myeloma and Leukemia, 17(8), 539-541. [More Information]

Zern, N., Clifton-Bligh, R., Gill, A., Aniss, A., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Sywak, M. (2017). Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy. Annals of Surgical Oncology, 24(9), 2611-2616. [More Information]

Chou, A., Hes, O., Turchini, J., Trpkov, K., Gill, A. (2017). Do significant TFE3 gene rearrangements occur in succinate dehydrogenase-deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution. Modern Pathology, 30(10), 1507-1508. [More Information]

Trpkov, K., Abou-Ouf, H., Hes, O., Lopez, J., Nesi, G., Comperat, E., Sibony, M., Osunkoya, A., Zhou, M., Gill, A., et al (2017). Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity. American Journal of Surgical Pathology, 41(10), 1299-1308. [More Information]

Wood, S., Gill, A., Brodsky, A., Lu, S., Friedman, K., Karashchuk, G., Lombardo, K., Yang, D., Resnick, M. (2017). Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon gamma pathway. Modern Pathology, 30(1), 123-133. [More Information]

Hosoda, W., Chianchiano, P., Griffin, J., Pittman, M., Brosens, L., Noe, M., Yu, J., Shindo, K., Suenaga, M., Samra, J., Gill, A., et al (2017). Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4. Journal of Pathology, 242(1), 16-23. [More Information]

De Sousa, S., McCabe, M., Wu, K., Roscioli, T., Gayevskiy, V., Brook, K., Rawlings, L., Scott, H., Thompson, T., Earls, P., Gill, A., et al (2017). Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours. European Journal of Endocrinology, 176(5), 635-644. [More Information]

Humphris, J., Patch, A., Nones, K., Bailey, P., Johns, A., McKay, S., Chang, D., Miller, D., Pajic, M., Samra, J., Kench, J., Gill, A., et al (2017). Hypermutation In Pancreatic Cancer. Gastroenterology, 152(1), 68-74.e2. [More Information]

Huang, Y., Chua, T., Gill, A., Samra, J. (2017). Impact of perioperative fluid administration on early outcomes after pancreatoduodenectomy: A meta-analysis. Pancreatology, 17(3), 334-341. [More Information]

Pickett, J., Chou, A., Andrici, J., Clarkson, A., Sioson, L., Sheen, A., Reagh, J., Najdawi, F., Kim, Y., Riley, D., Gard, G., Hogg, R., Turchini, J., Gill, A., et al (2017). Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required. American Journal of Surgical Pathology, 41(10), 1433-1442. [More Information]

Nahm, C., De Reuver, P., Hugh, T., Pearson, A., Gill, A., Samra, J., Mittal, A. (2017). Intra-Operative Amylase Concentration in Peri-Pancreatic Fluid Predicts Pancreatic Fistula After Distal Pancreatectomy. Journal of Gastrointestinal Surgery, 21(6), 1031-1037. [More Information]

Najdawi, F., Crook, A., Maidens, J., McEvoy, C., Fellowes, A., Pickett, J., Ho, M., Nevell, D., Mcilroy, K., Sheen, A., Turchini, J., Hogg, R., Gard, G., Gill, A., et al (2017). Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Pathology, 49(5), 457-464. [More Information]

Chui, J., Singh, A., Gill, A. (2017). Loss of BAP1 expression is very rare in breast carcinoma. Pathology, 49(5), 557-560. [More Information]

Johns, A., McKay, S., Humphris, J., Pinese, M., Chantrill, L., Mead, S., Tucker, K., Andrews, L., Goodwin, A., Leonard, C., Pavlakis, N., Gill, A., et al (2017). Lost in translation: Returning germline genetic results in genome-scale cancer research. Genome Medicine, 9(1), 1-9. [More Information]

Reagh, J., Bullock, M., Andrici, J., Turchini, J., Sioson, L., Clarkson, A., Watson, N., Sheen, A., Lim, G., Delbridge, L., Sidhu, S., Sywak, M., Field, M., Learoyd, D., Robinson, B., Clifton-Bligh, R., Gill, A., et al (2017). NRASQ61R mutation-specific immunohistochemistry also identifies the HRASQ61R mutation in medullary thyroid cancer and may have a role in triaging genetic testing for MEN2. American Journal of Surgical Pathology, 41(1), 75-81. [More Information]

Turchini, J., Andrici, J., Sioson, L., Clarkson, A., Watson, N., Toon, C., Shepherd, P., Ng, D., Dixon-McIver, A., Oei, P., Gill, A. (2017). NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma. Applied Immunohistochemistry and Molecular Morphology, 25(7), 475-480. [More Information]

Nahm, C., Norton, I., Cho, S., Gill, A., Samra, J., Mittal, A. (2017). Pancreatic cystic lesions: Sorting benign from malignant. Medicine Today, 18(4), 55-61.

Nahm, C., Mittal, A., Gill, A., Samra, J. (2017). Pancreatic rheumatoid nodule case report and review of the literature. Pancreapedia:Exocrine Pancreas Knowledge Base, 46(5), e45-e47. [More Information]

Nahm, C., Mittal, A., Gill, A., Samra, J. (2017). Pancreatic Rheumatoid Nodule: Case Report and Review of the Literature. Pancreas, 46(5), e45-e47.

Chua, T., Mittal, A., Arena, J., Sheen, A., Gill, A., Samra, J. (2017). Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma. The American Journal Of Surgery, 213(6), 1072-1076. [More Information]

Schlichtemeier, S., Logaraj, A., Gill, A., Engel, A. (2017). Response to Bethune et al. Colorectal Disease, 19(6), 589-600. [More Information]

Itchins, M., Arena, J., Nahm, C., Rabindran, J., Kim, S., Gibbs, E., Bergamin, S., Chua, T., Gill, A., Maher, R., Diakos, C., Mittal, A., Hruby, G., Kneebone, A., Pavlakis, N., Samra, J., Clarke, S., et al (2017). Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre. European Journal of Surgical Oncology, 43(9), 1711-1717. [More Information]

Selinger, C., Li, B., Pavlakis, N., Links, M., Gill, A., Lee, A., Clarke, S., Tran, T., Lum, T., Yip, P., Horvath, L., Yu, B., O’Toole, S., Cooper, W., et al (2017). Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target. Histopathology, 70(3), 402-411. [More Information]

Chan, J., Chan, D., Diakos, C., Engel, A., Pavlakis, N., Gill, A., Clarke, S. (2017). The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Annals of Surgery, 265(3), 539-546. [More Information]

Vennin, C., Chin, V., Warren, S., Lucas, M., Herrmann, D., Magenau, A., Melenec, P., Walters, S., del Monte-Nieto, G., Conway, J., Jain, R., Weninger, W., Johns, A., Gill, A., et al (2017). Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Science Translational Medicine, 9(384), 1-17. [More Information]

Itchins, M., Chia, P., Hayes, S., Howell, V., Gill, A., Cooper, W., John, T., Mitchell, P., Millward, M., Clarke, S., Pavlakis, N., et al (2017). Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context. Asia-Pacific Journal of Clinical Oncology, 13, 3-13. [More Information]

Kim, E., Wright, M., Sioson, L., Novos, T., Gill, A., Benn, D., White, C., Dwight, T., Clifton-Bligh, R. (2017). Utility of the succinate: Fumarate ratio for assessing SDH dysfunction in different tumor types. Molecular Genetics and Metabolism Reports, 10, 45-49. [More Information]

Scarpa, A., Chang, D., Nones, K., Corbo, V., Patch, A., Bailey, P., Lawlor, R., Johns, A., Miller, D., Lau, L., Lee, M., Pickett, H., Reddel, R., Samra, J., Kench, J., Gill, A., et al (2017). Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 543(7643), 65-71. [More Information]

Barazeghi, E., Gill, A., Sidhu, S., Norlen, O., Dina, R., Palazzo, F., Hellman, P., Stalberg, P., Westin, G. (2016). 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma. Clinical Epigenetics, 8(1), 1-11. [More Information]

Schlichtemeier, S., Pang, T., Williams, N., Gill, A., Smith, R., Samra, J., Lam, V., Hollands, M., Richardson, A., Pleass, H., Hugh, T., et al (2016). A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience. European Journal of Surgical Oncology, 42(10), 1576-1583. [More Information]

Gingras, M., Covington, K., Chang, D., Donehower, L., Gill, A., Ittmann, M., Creighton, C., Johns, A., Shinbrot, E., Dewal, N., Samra, J., et al (2016). Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Reports, 14(4), 907-919. [More Information]

Papathomas, T., Pucci, E., Giordano, T., Lu, H., Duregon, E., volante, M., Papotti, M., Lloyd, R., Tischler, A., Turchini, J., Gill, A., et al (2016). An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma. The American Journal of Surgical Pathology, 40(4), 569-576. [More Information]

Julovi, S., Xue, A., Thanh LE, T., Gill, A., Bulanadi, J., Patel, M., Waddington, L., Rye, K., Moghaddam, M., Smith, R. (2016). Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo. PloS One, 11(3), 1-14. [More Information]

Cole, A., Dwight, T., Gill, A., Dickson, K., Zhu, Y., Clarkson, A., Gard, G., Maidens, J., Valmadre, S., Clifton-Bligh, R., Marsh, D. (2016). Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Scientific Reports, 6, 1-12. [More Information]

Fraser, S., Go, C., Aniss, A., Sidhu, S., Delbridge, L., Learoyd, D., Clifton-Bligh, R., Tacon, L., Tsang, V., Robinson, B., Gill, A., Sywak, M. (2016). BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer. World Journal of Surgery, 40(7), 1618-1624. [More Information]

Zheng, S., Cherniack, A., Dewal, N., Moffitt, R., Danilova, L., Murray, B., Lerario, A., Else, T., Knijnenburg, T., Gill, A., Sidhu, S., et al (2016). Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell, 29(5), 723-736. [More Information]

Gill, A., Amin, M., Smith, S., Trpkov, K. (2016). Succinate dehydrogenase-deficient renal carcinoma. In Moch, H., Humphrey, P.A., Ulbright, T.M., Reuter, V.E. (Eds.), World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs, (pp. 25-26). Lyons: IARC Press.

Glastras, S., Chen, H., McGrath, R., Zaky, A., Gill, A., Pollock, C., Saad, S. (2016). Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity. Scientific Reports, 6, 1-12. [More Information]

Trpkov, K., Hes, O., Bonert, M., Lopez, J., Bonsib, S., Nesi, G., Comperat, E., Sibony, M., Berney, D., et al, Gill, A. (2016). Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women. The American Journal of Surgical Pathology, 40(1), 60-71. [More Information]

Bogun, Y., Sioson, L., Watson, N., Pickett, J., Gill, A. (2016). False-positive EGFR Mutation-specific Immunohistochemistry in HER2-positive Breast Cancers: A Potential Diagnostic Pitfall. Applied Immunohistochemistry and Molecular Morphology, 24(3), 227-227. [More Information]

Trpkov, K., Hes, O., Agaimy, A., Bonert, M., Martinek, P., Magi-Galluzzi, C., Kristiansen, G., Luders, C., Nesi, G., Gill, A., et al (2016). Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. The American Journal of Surgical Pathology, 40(7), 865-875. [More Information]

Harrison, W., Andrici, J., Maclean, F., Madadi-Ghahan, R., Farzin, M., Sioson, L., Toon, C., Clarkson, A., Watson, N., Pickett, J., Anderson, L., Clifton-Bligh, R., Dwight, T., Gill, A., et al (2016). Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings. American Journal of Surgical Pathology, 40(5), 599-607. [More Information]

Bailey, P., Chang, D., Nones, K., Johns, A., Patch, A., Gingras, M., Miller, D., Christ, A., Bruxner, T., Quinn, M., Samra, J., Kench, J., Gill, A., et al (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52. [More Information]

Chua, T., Gill, P., Gill, A., Samra, J. (2016). Ileocecal Intussusception Caused by an Appendiceal Neoplasm. Journal of Gastrointestinal Surgery, 20(4), 867-868. [More Information]

de Reuver, P., Mehta, S., Gill, P., Andrici, J., D’Urso, L., Clarkson, A., Mittal, A., Hugh, T., Samra, J., Gill, A. (2016). Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors. American College of Surgeons. Journal, 222(3), 281-287. [More Information]

McKay, S., Humphris, J., Johns, A., Gill, A., Tucker, K. (2016). Inherited pancreatic cancer. Cancer Forum, 40(1), 30-33.

Wong, Y., Sharifah, N., Tan, G., Gill, A., Ali, S. (2016). Intrathyroidal oxyphilic parathyroid carcinoma: A potential diagnostic caveat in cytology? Diagnostic Cytopathology, 14(8), 688-692. [More Information]

Reagh, J., Eckstein, R., Selinger, C., Evans, J., O’Toole, S., Gill, A. (2016). Liposarcoma masquerading as an inflammatory pseudotumor: a case report. Journal of Medical Case Reports, 10(1), 1-3. [More Information]

Tayao, M., Andrici, J., Farzin, M., Clarkson, A., Sioson, L., Watson, N., Chua, T., Sztynda, T., Samra, J., Gill, A. (2016). Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma. PloS One, 11(3), 1-11. [More Information]

Andrici, J., Jung, J., Sheen, A., D’Urso, L., Sioson, L., Pickett, J., Parkhill, T., Verdonk, B., Wardell, K., Singh, A., Clarkson, A., Watson, N., Toon, C., Gill, A. (2016). Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma. Human Pathology, 51, 9-15. [More Information]

Andrici, J., Goeppert, B., Sioson, L., Clarkson, A., Renner, M., Stenzinger, A., Tayao, M., Watson, N., Farzin, M., Toon, C., Smith, R., Mittal, A., Samra, J., Hugh, T., Gill, A., et al (2016). Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma. Medicine, 95(2), 1-8. [More Information]

Andrici, J., Parkhill, T., Jung, J., Wardell, K., Verdonk, B., Singh, A., Sioson, L., Clarkson, A., Watson, N., Sheen, A., Toon, C., Gill, A., et al (2016). Loss of expression of BAP1 is very rare in non-small cell lung carcinoma. Pathology, 48(4), 336-340. [More Information]

Ahadi, M., Andrici, J., Sioson, L., Sheen, A., Clarkson, A., Gill, A. (2016). Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma. Human Pathology, 57, 91-97. [More Information]

Wang, J., Andrici, J., Sioson, L., Clarkson, A., Sheen, A., Farzin, M., Toon, C., Turchini, J., Gill, A. (2016). Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. Human Pathology, 55, 83-90. [More Information]

Friedman, K., Brodsky, A., Lu, S., Wood, S., Gill, A., Lombardo, K., Yang, D., Resnick, M. (2016). Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Modern Pathology, 29(5), 528-541. [More Information]

Andrici, J., Farzin, M., Sioson, L., Clarkson, A., Watson, N., Toon, C., Gill, A. (2016). Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer. Modern Pathology, 29(3), 266-274. [More Information]

Gifford, G., Gill, A., Stevenson, W. (2016). Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists. Pathology, 48(1), 5-16. [More Information]

Andrici, J., Farzin, M., Clarkson, A., Sioson, L., Sheen, A., Watson, N., Toon, C., Koleth, M., Stevenson, W., Gill, A. (2016). Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms. Pathology, 48(4), 319-324. [More Information]

Annamalai, A., Sampathkumar, K., Kane, S., Shetty, N., Kulkarni, S., Rangarajan, V., Purandare, N., Pai, P., Mahuvakar, A., et al, Gill, A., Clifton-Bligh, R. (2016). Needle(s) in the haystack- synchronous multifocal tumor induced osteomalacia. Journal of Clinical Endocrinology and Metabolism, 101(2), 390-393. [More Information]

Yakirevich, E., Resnick, M., Mangray, S., Wheeler, M., Jackson, C., Lombardo, K., Lee, J., Kim, K., Gill, A., Wang, K., et al (2016). Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. Clinical Cancer Research, 22(15), 3831-3840. [More Information]

Chua, T., Petrushnko, W., Mittal, A., Gill, A., Samra, J. (2016). Pancreatic Metastasectomy-an Analysis of Survival Outcomes and Prognostic Factors. Journal of Gastrointestinal Surgery, 20(6), 1188-1193. [More Information]

Flynn, A., Dwight, T., Harris, J., Benn, D., Zhou, L., Hogg, A., Catchpoole, D., James, P., Duncan, E., Trainer, A., Gill, A., Clifton-Bligh, R., et al (2016). Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 101(3), 1034-1043. [More Information]

Pinho, A., Mawson, A., Gill, A., Arshi, M., Warmerdam, M., Giry-Laterriere, M., Eling, N., Lie, T., Kuster, E., Camargo, S., et al (2016). Sirtuin1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions. Oncotarget, 7(46), 74768-74778. [More Information]

Chua, T., Yang, T., Gill, A., Samra, J. (2016). Systematic Review and Meta-Analysis of Enucleation Versus Standardized Resection for Small Pancreatic Lesions. Annals of Surgical Oncology, 23(2), 592-599. [More Information]

Charles (nee Slaviero), K., Harris, B., Haddad, C., Clarke, S., Guminski, A., Stevens, M., Dodds, T., Gill, A., Back, M., Veivers, D., Eade, T. (2016). Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and nonoropharyngeal patients. BMC Cancer, 16(1), 1-13. [More Information]

Bullock, M., Ren, Y., O’Neill, C., Gill, A., Aniss, A., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., de Vathaire, F., Robinson, B., Clifton-Bligh, R. (2016). TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas. Clinical Endocrinology, 85(2), 283-290. [More Information]

Gallinger, B., Druker, H., Gill, A., Wasserman, J., Kim, R. (2016). The adrenal gland: An evolution of the roles of genetic counsellors and medical geneticists in endocrine cancers. Diagnostic Histopathology, 22(3), 108-122. [More Information]

Raut, A., Andrici, J., Severino, A., Gill, A. (2016). The death of the hospital autopsy in Australia? The hospital autopsy rate is declining dramatically. Pathology, 48(7), 645-649. [More Information]

Dickson, K., Cole, A., Gill, A., Clarkson, A., Gard, G., Chou, A., Kennedy, C., Henderson, B., Fereday, S., Traficante, N., deFazio, A., Clifton-Bligh, R., Marsh, D., et al (2016). The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer. Human Molecular Genetics, 25(24), 5460-5471. [More Information]

Huang, C., Zhang, Y., Kelly, D., Tan, C., Gill, A., Cheng, D., Braet, F., Park, J., Sue, C., Pollock, C., Chen, X. (2016). Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway. Scientific Reports, 6, 1-13. [More Information]

Chua, T., de Reuver, P., Staerkle, R., Neale, M., Arena, J., Mittal, A., Shanbhag, S., Gill, A., Samra, J. (2016). Transverse closure of mesenterico-portal vein after vein resection in pancreatoduodenectomy. European Journal of Surgical Oncology, 42(2), 211-218. [More Information]

Smith, S., Trpkov, K., Chen, Y., Mehra, R., Sirohi, D., Ohe, C., Cani, A., Hovelson, D., Omata, K., Gill, A., et al (2016). Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma. American Journal of Surgical Pathology, 40(11), 1457-1472. [More Information]

Donaldson, L., Gill, A., Hibbert, M. (2016). Utility of surgical lung biopsy in critically ill patients with diffuse pulmonary infiltrates: a retrospective review. Internal Medicine Journal, 46(11), 1306-1310. [More Information]

Beadnall, H., Gill, A., Riminton, S., Barnett, M. (2016). Virus-related Merkel cell carcinoma complicating fingolimod treatment for multiple sclerosis. Neurology, 87(24), 2595-2597. [More Information]

Chou, A., Fraser, S., Toon, C., Clarkson, A., Sioson, L., Farzin, M., Cussigh, C., Aniss, A., O’Neill, C., Watson, N., Clifton-Bligh, R., Learoyd, D., Robinson, B., Delbridge, L., Sidhu, S., O’Toole, S., Sywak, M., Gill, A., et al (2015). A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma. American Journal of Surgical Pathology, 39(5), 652-659. [More Information]

Xue, A., Julovi, S., Hugh, T., Samra, J., Wong, M., Gill, A., Toon, C., Smith, R. (2015). A patient-derived subrenal capsule xenograft model can predict response to adjuvant therapy for cancers in the head of the pancreas. Pancreatology, 15(4), 397-404. [More Information]

Houang, M., Toon, C., Clarkson, A., Sioson, L., de Silva, K., Watson, N., Singh, N., Chou, A., Gill, A. (2015). ALK and ROS1 overexpression is very rare in colorectal adenocarcinoma. Applied Immunohistochemistry and Molecular Morphology, 23(2), 134-138. [More Information]

Chua, T., Gill, A., Samra, J. (2015). An unusual cause of torrential lower gastrointestinal hemorrhage. Gastroenterology, 148(5), 10-11. [More Information]

Dodds, T., D’Urso, L., Gill, A. (2015). BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry. Pathology, 47(6), 591-593. [More Information]

Vonhoff, C., Lochhead, A., Koustais, S., Watson, N., Andrici, J., Brewer, J., Gill, A. (2015). Differences in the Pathological Diagnosis and Repeat Craniotomy Rates in Cerebral Tumors Undergoing Biopsy or Resection in an Urban Versus Regional Center. Medicine, 94(47), 1-7. [More Information]

Mittal, A., de Reuver, P., Shanbhag, S., Staerkle, R., Neale, M., Thoo, C., Hugh, T., Gill, A., Samra, J. (2015). Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): Common hepatic arterial stump pressure should determine the need for arterial reconstruction. Surgery, 157(4), 811-817. [More Information]

Gundara, J., Gill, A., Samra, J. (2015). Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinoma. Oncology Letters, 10(2), 744-748. [More Information]

Selinger, C., Cooper, W., Lum, T., McNeil, C., Morey, A., Waring, P., Amanuel, B., Millward, M., Peverall, J., Van Vliet, C., Pavlakis, N., Gill, A., et al (2015). Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing. Histopathology, 67(5), 654-663. [More Information]

de Reuver, P., Mittal, A., Neale, M., Gill, A., Samra, J. (2015). Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity. Surgery, 158(1), 183-190. [More Information]

Collins, J., Gill, A., Bell, C., Kellow, J. (2015). Gastroenterology: Rare cause of upper gastrointestinal bleeding. Journal of Gastroenterology and Hepatology, 30(10), 1445-1445. [More Information]

Martinek, P., Grossmann, P., Hes, O., Bouda, J., Eret, V., Frizzell, N., Gill, A., Ondic, O. (2015). Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC). Virchows Archiv: an international journal of pathology, 467(2), 185-191. [More Information]

Pantaleo, M., Lolli, C., Nannini, M., Astolfi, A., Indio, V., Saponara, M., Urbini, M., La Rovere, S., Gill, A., Goldstein, D., et al (2015). Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations. Genetics in Medicine, 17(5), 391-395. [More Information]

Cheng, J., Gill, A., Kumar, S. (2015). Granulosa cell tumour of the adrenal. Pathology, 47(5), 487-489. [More Information]

Ip, J., Pang, T., Glover, A., Soon, P., Zhao, J., Clarke, S., Robinson, B., Gill, A., Sidhu, S. (2015). Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers. The Oncologist, 20(3), 247-256. [More Information]

Elston, M., Meyer-Rochow, G., Conaglen, H., Clarkson, A., Clifton-Bligh, R., Conaglen, J., Gill, A. (2015). Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas. Human Pathology, 46(3), 390-396. [More Information]

Glover, A., Zhao, J., Ip, J., Lee, J., Robinson, B., Gill, A., Soon, P., Sidhu, S. (2015). Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence. Endocrine-Related Cancer, 22(1), 99-109. [More Information]

Andrici, J., Sheen, A., Sioson, L., Wardell, K., Clarkson, A., Watson, N., Ahadi, M., Farzin, M., Toon, C., Gill, A. (2015). Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology. Modern Pathology, 28(10), 1360-1368. [More Information]

Farzin, M., Toon, C., Clarkson, A., Sioson, L., Watson, N., Andrici, J., Gill, A. (2015). Loss of expression of BAP1 predicts longer survival in mesothelioma. Pathology, 47(4), 302-307. [More Information]

Knox, R., Luey, N., Sioson, L., Kedziora, A., Clarkson, A., Watson, N., Toon, C., Cussigh, C., Pincott, S., Pillinger, S., Salama, Y., Evans, J., Percy, J., Schnitzler, M., Engel, A., Gill, A. (2015). Medullary Colorectal Carcinoma Revisited: A Clinical and Pathological Study of 102 Cases. Annals of Surgical Oncology, 22, 2988-2996. [More Information]

Chandrasegaram, M., Goldstein, D., Simes, R., Gebski, V., Kench, J., Gill, A., Samra, J., Merrett, N., Richardson, A., Barbour, A. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British Journal of Surgery, 102(12), 1459-1472. [More Information]

Glover, A., Zhao, J., Gill, A., Weiss, J., Mugridge, N., Kim, E., Feeney, A., Ip, J., Reid, G., Clarke, S., Robinson, B., Sidhu, S., et al (2015). microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma. Oncotarget, 6(34), 36675-36688. [More Information]

Ip, J., Pang, T., Pon, C., Zhao, J., Sywak, M., Gill, A., Soon, P., Sidhu, S. (2015). Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism. ANZ Journal of Surgery, 85(4), 279-283. [More Information]

Gundara, J., Zhao, J., Gill, A., Lee, J., Delbridge, L., Robinson, B., McLean, C., Serpell, J., Sidhu, S. (2015). Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer. Cancer Medicine, 4(2), 174-182. [More Information]

Howson, P., Kruijff, S., Aniss, A., Pennington, T., Gill, A., Dodds, T., Delbridge, L., Sidhu, S., Sywak, M. (2015). Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation. Endocrine Pathology, 26(3), 250-254. [More Information]

Chan, D., Clarke, S., Gill, A., Chantrill, L., Samra, J., Li, B., Barnes, T., Nahar, K., Pavlakis, N. (2015). Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report. Molecular and Clinical Oncology, 3(4), 817-819. [More Information]

Pang, T., Kaufman, A., Choi, J., Gill, A., Drummond, M., Hugh, T., Samra, J. (2015). Peroxisome proliferator-activated receptor-α staining is associated with worse outcome in colorectal liver metastases. Molecular and Clinical Oncology, 3(2), 308-316. [More Information]

Chantrill, L., Nagrial, A., Watson, C., Johns, A., Martyn-Smith, M., Simpson, S., Mead, S., Jones, M., Samra, J., Gill, A., Chin, V., Sebastian, L., Sjoquist, K., Yip, S., Pavlakis, N., Grimison, P., Simes, R., et al (2015). Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Clinical Cancer Research, 21(9), 2029-2037. [More Information]

Luchini, C., Veronese, N., Solmi, M., Cho, H., Kim, J., Chou, A., Gill, A., Faraj, S., Chaux, A., Netto, G., et al (2015). Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget, 6(36), 39088-39097. [More Information]

Gundara, J., Gill, A., Glover, A., Benson, K., Clifton-Bligh, R., Roxburgh, S., Sywak, M. (2015). Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluation. ANZ Journal of Surgery, 85(4), 289-290. [More Information]

Chin, V., Nagrial, A., Chou, A., Biankin, A., Gill, A., Timpson, P., Pajic, M. (2015). Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities. Expert Reviews in Molecular Medicine, 17, 1-14. [More Information]

Norlen, O., Charlton, A., Sarkis, L., Henwood, T., Shun, A., Gill, A., Delbridge, L. (2015). Risk of malignancy for each Bethesda class in pediatric thyroid nodules. Journal of Pediatric Surgery, 50(7), 1147-1149. [More Information]

Papathomas, T., Oudijk, L., Persu, A., Gill, A., van Nederveen, F., Tischler, A., Tissier, F., volante, M., Matias-Guiu, X., Smid, M., Clifton-Bligh, R., et al (2015). SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors ([email protected]). Modern Pathology, 28(6), 807-821. [More Information]

Mehta, S., de Reuver, P., Gill, P., Andrici, J., D’Urso, L., Mittal, A., Pavlakis, N., Clarke, S., Samra, J., Gill, A. (2015). Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors. Medicine, 94(40), 1-6. [More Information]

Flynn, A., Benn, D., Clifton-Bligh, R., Robinson, B., Trainer, A., James, P., Hogg, A., Waldeck, K., George, J., Li, J., Gill, A., et al (2015). The genomic landscape of phaeochromocytoma. Journal of Pathology, 236(1), 78-89. [More Information]

Clugston, E., Gill, A., Grat, N., Bonar, S., Gill, A. (2015). Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal tumour. Pathology, 47(2), 173-175. [More Information]

Wong, S., Waldeck, K., Vergara, I., Schroder, J., Madore, J., Wilmott, J., Colebatch, A., De Paoli-Iseppi, R., Li, J., Lupat, R., Hruby, G., Mann, G., Thompson, J., Scolyer, R., Gill, A., et al (2015). UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas. Cancer Research, 75(24), 5228-5234. [More Information]

Waddell, N., Pajic, M., Patch, A., Chang, D., Kassahn, K., Bailey, P., Johns, A., Miller, D., Nones, K., Quek, K., Samra, J., Kench, J., Gill, A., et al (2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature, 518(7540), 495-501. [More Information]

Luey, N., Toon, C., Sioson, L., Clarkson, A., Watson, N., Cussigh, C., Kedziora, A., Pincott, S., Pillinger, S., Evans, J., Percy, J., Engel, A., Schnitzler, M., Gill, A. (2014). A further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinoma. PloS One, 9(8), 1-5. [More Information]

Tan, M., Yee, G., Jorgensen, J., Kuzinkovas, V., Talbot, M., Loi, K., Viswanathan, S., Gill, A. (2014). A histologic evaluation of the laparoscopic adjustable gastric band capsule by tissue sampling during sleeve gastrectomy performed at different time points after band removal. Surgery for Obesity and Related Diseases, 10(4), 620-625. [More Information]

Wang, F., Gill, A., Neale, M., Puttaswamy, V., Gananadha, S., Pavlakis, N., Clarke, S., Hugh, T., Samra, J. (2014). Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma. Annals of Surgical Oncology, 21(6), 1937-1947. [More Information]

Norlen, O., Popadich, A., Kruijff, S., Gill, A., Sarkis, L., Delbridge, L., Sywak, M., Sidhu, S. (2014). Bethesda III Thyroid Nodules: The Role of Ultrasound in Clinical Decision Making. Annals of Surgical Oncology, 21(11), 3528-3533. [More Information]

Farzin, M., Toon, C., Clarkson, A., Sioson, L., Gill, A. (2014). BRAF V600E mutation specific immunohistochemistry with clone VE1 is not reliable in pituitary adenomas. Pathology, 46(1), 79-80. [More Information]

Humphris, J., Johns, A., Simpson, S., Cowley, M., Pajic, M., Chang, D., Nagrial, A., Chin, V., Chantrill, L., Pinese, M., Gill, A., Samra, J., Kench, J., et al (2014). Clinical and pathologic features of familial pancreatic cancer. Cancer, 120(23), 3669-3675. [More Information]

Wong, M., Xue, A., Julovi, S., Pavlakis, N., Samra, J., Hugh, T., Gill, A., Peters, L., Baxter, R., Smith, R. (2014). Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma. Clinical Cancer Research, 20(10), 4047-4058. [More Information]

Houang, M., Sioson, L., Clarkson, A., Watson, N., Mahtab, F., Toon, C., Raut, A., O’Toole, S., Cooper, W., Pavlakis, N., Gill, A., et al (2014). EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer. Pathology, 46(6), 501-508. [More Information]

Kozor, R., Pollock, C., Gill, A., Bhindi, R., Figtree, G. (2014). Fabry disease deposition mimicking a cardiac tumour and precipitating heart block. European Heart Journal – Cardiovascular Imaging, 15(8), 869-869. [More Information]

Pang, T., Wilson, O., Argueta, M., Hugh, T., Chou, A., Samra, J., Gill, A. (2014). Frozen section of the pancreatic neck margin in pancreatoduodenectomy for pancreatic adenocarcinoma is of limited utility. Pathology, 46(3), 188-192. [More Information]

Nones, K., Waddell, N., Song, S., Patch, A., Miller, D., Johns, A., Wu, J., Kassahn, K., Wood, D., Bailey, P., Gill, A., et al (2014). Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. International Journal of Cancer, 135(5), 1110-1118. [More Information]

Toon, C., Chou, A., Clarkson, A., de Silva, K., Houang, M., Chan, J., Sioson, L., Jankova, L., Gill, A. (2014). Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer. PloS One, 9(2), 1-7. [More Information]

Chou, A., Toon, C., Clarkson, A., Sioson, L., Houang, M., Watson, N., DeSilva, K., Gill, A. (2014). Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency. Human Pathology, 45(8), 1697-1703. [More Information]

Kruijff, S., Sidhu, S., Sywak, M., Gill, A., Delbridge, L. (2014). Negative Parafibromin Staining Predicts Malignant Behavior in Atypical Parathyroid Adenomas. Annals of Surgical Oncology, 21, 426-433. [More Information]

Gundara, J., Zhao, J., Gill, A., Clifton-Bligh, R., Robinson, B., Delbridge, L., Sidhu, S. (2014). Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ Journal of Surgery, 84(4), 235-239. [More Information]

Tsang, V., Dwight, T., Benn, D., Meyer-Rochow, G., Gill, A., Sywak, M., Sidhu, S., Veivers, D., Sue, C., Robinson, B., Clifton-Bligh, R., Parker, N. (2014). Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Endocrine-Related Cancer, 21(3), 415-426. [More Information]

Baker, L., Gill, A., Chan, C., Lin, B., Crawford, B. (2014). Parasitic thyroid nodules: cancer or not? Endocrinology, Diabetes & Metabolism Case Reports, 2014, 1-5. [More Information]

Kruijff, S., Petersen, J., Chen, P., Aniss, A., Clifton-Bligh, R., Sidhu, S., Delbridge, L., Gill, A., Learoyd, D., Sywak, M. (2014). Patterns of Structural Recurrence in Papillary Thyroid Cancer. World Journal of Surgery, 38(3), 653-659. [More Information]

Houang, M., Toon, C., Clarkson, A., Sioson, L., Watson, N., Farzin, M., Selinger, C., Chou, A., Morey, A., Cooper, W., O’Toole, S., Gill, A. (2014). Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer. Pathology, 46(5), 383-388. [More Information]

Paik, J., Toon, C., Benn, D., High, H., Hasovitz, C., Pavlakis, N., Clifton-Bligh, R., Gill, A. (2014). Renal Carcinoma Associated With Succinate Dehydrogenase B Mutation: A New and Unique Subtype of Renal Carcinoma. Journal of Clinical Oncology, 32(6), e10-e13. [More Information]

Johns, A., Miller, D., Simpson, S., Gill, A., Kassahn, K., Humphris, J., Samra, J., Tucker, K., Andrews, L., Chang, D., et al (2014). Returning individual research results for genome sequences of pancreatic cancer. Genome Medicine, 6(5), 1-8. [More Information]

Wong, M., Saad, S., Zhang, J., Gross, S., Jarolimek, W., Schilter, H., Chen, J., Gill, A., Pollock, C., Wong, M. (2014). Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model. AJP: Renal Physiology (Online), 307(8), F908-F916. [More Information]

Toon, C., Hasovits, C., Paik, J., Field, M., Chou, A., Hugh, T., Pavlakis, N., Gill, A. (2014). Skin rash, a kidney mass and a family mystery dating back to World War II. Medical Journal of Australia, 201(1), 58-60. [More Information]

Kumarasinghe, M., Brown, I., Raftopoulos, S., Bourke, M., Charlton, A., de Boer, W., Eckstein, R., Epari, K., Gill, A., Lam, A., et al (2014). Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations. Pathology, 46(6), 473-480. [More Information]

Gill, A., Hes, O., Papathomas, T., Sedivcova, M., Tan, P., Agaimy, A., Andresen, P., Kedziora, A., Clarkson, A., Toon, C., Sioson, L., Clifton-Bligh, R., Robinson, B., Benn, D., et al (2014). Succinate dehydrogenase (SDH)-deficient renal carcinoma: A morphologically distinct entity: A clinicopathologic series of 36 tumors from 27 patients. The American Journal of Surgical Pathology, 38(12), 1588-1602. [More Information]

Sarkis, L., Norlen, O., Aniss, A., Watson, N., Delbridge, L., Sidhu, S., Sywak, M., Gill, A. (2014). The Australian experience with the Bethesda classification system for thyroid fine needle aspiration biopsies. Pathology, 46(7), 592-595. [More Information]

Al-Odat, I., Chen, H., Chan, Y., Amgad, S., Wong, M., Gill, A., Pollock, C., Saad, S. (2014). The Impact of Maternal Cigarette Smoke Exposure in a Rodent Model on Renal Development in the Offspring. PloS One, 9(7), 1-10. [More Information]

Alvarado-Bachmann, R., Smith, A., Gundara, J., Kuo, S., Gill, A., Samra, J., Hugh, T. (2014). The incidence of mismatch repair gene defects in colorectal liver metastases. Molecular Medicine Reports, 10(2), 1003-1006. [More Information]

Guo, J., Tretiakova, M., Troxell, M., Osunkoya, A., Fadare, O., Sangoi, A., Shen, S., Lopez-Beltran, A., Mehra, R., Heider, A., Gill, A., et al (2014). Tuberous Sclerosis-associated Renal Cell Carcinoma: A Clinicopathologic Study of 57 Separate Carcinomas in 18 Patients. The American Journal of Surgical Pathology, 38(11), 1457-1467. [More Information]

Gill, A. (2014). Understanding the Genetic Basis of Parathyroid Carcinoma. Endocrine Pathology, 25(1), 30-34. [More Information]

Huang, C., Shen, S., Ma, Q., Chen, J., Gill, A., Pollock, C., Chen, X. (2013). Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice. Diabetes, 62(8), 2923-2934. [More Information]

Toon, C., Walsh, M., Chou, A., Capper, D., Clarkson, A., Sioson, L., Clarke, S., Mead, S., Walters, R., Clendenning, M., Gill, A., et al (2013). BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome. American Journal of Surgical Pathology, 37(10), 1592-1602. [More Information]

Soon, P., Kim, E., Pon, C., Gill, A., Moore, K., Spillane, A., Benn, D., Baxter, R. (2013). Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocrine-Related Cancer, 20(1), 1-12. [More Information]

Grieve, S., Lonborg, J., Mazhar, J., Tan, T., Ho, E., Liu, C., Lay, W., Gill, A., Kuchel, P., Bhindi, R., Figtree, G. (2013). Cardiac magnetic resonance imaging of rapid VCAM-1 up-regulation in myocardial ischemia-reperfusion injury. European Biophysics Journal, 42(1), 61-70. [More Information]

Dwight, T., Mann, K., Benn, D., Robinson, B., McKelvie, P., Gill, A., Winship, I., Clifton-Bligh, R. (2013). Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma. The Journal of Clinical Endocrinology and Metabolism, 98(6), E1103-E1108. [More Information]

Gill, A., Lipton, L., Taylor, J., Benn, D., Richardson, A., Frydenberg, M., Shapiro, J., Clifton-Bligh, R., Chow, C., Bogwitz, M. (2013). Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma. Pathology, 45(7), 689-691. [More Information]

Chang, D., Jamieson, N., Johns, A., Scarlett, C., Pajic, M., Chou, A., Pinese, M., Humphris, J., Jones, M., Toon, C., Samra, J., Kench, J., Gill, A., et al (2013). Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater. Journal of Clinical Oncology, 31(10), 1348-1356. [More Information]

Clifton-Bligh, R., Hofman, M., Duncan, E., Sim, L., Darnell, D., Clarkson, A., Wong, T., Walsh, J., Gill, A., Ebeling, P., et al (2013). Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET/CT. Journal of Clinical Endocrinology and Metabolism, 98(2), 687-694. [More Information]

Gundara, J., Gill, A., Neale, M., Collins, P., Hugh, T., Samra, J. (2013). Inferior vena cava epithelioid hemangioendothelioma. Journal Of Vascular Surgery, 1(1), 75-77. [More Information]

Wang, L., Versnick, M., Gill, A., Lee, J., Sidhu, S., Sywak, M., Delbridge, L. (2013). Level VII is an Important Component of Central Neck Dissection for Papillary Thyroid Cancer. Annals of Surgical Oncology, 20(7), 2261-2265. [More Information]

Dwight, T., Benn, D., Clarkson, A., Vilain, R., Lipton, L., Robinson, B., Clifton-Bligh, R., Gill, A. (2013). Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology, 37(2), 226-233. [More Information]

McCormack, A., Kaplan, W., Gill, A., Little, N., Cook, R., Robinson, B., Clifton-Bligh, R. (2013). MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary, 16(2), 208-219. [More Information]

Gill, A. (2013). Of mice and men.. and models of metastatic colorectal carcinoma. Colorectal Disease, 15(7), 805-806. [More Information]

Houang, M., Clarkson, A., Sioson, L., Elston, M., Clifton-Bligh, R., Dray, M., Ranchere-Vince, D., Decouvelaere, A., de la Fouchardiere, A., Gill, A. (2013). Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Human Pathology, 44(12), 2711-2718. [More Information]

Gundara, J., Gill, A., Hugh, T., Samra, J. (2013). Redefining the apical lymph node at right hemicolectomy. European Journal of Surgical Oncology, 39(6), 662-665. [More Information]

Hasovits, C., Pavlakis, N., Howell, V., Gill, A., Clarke, S. (2013). Resistance to EGFR targeted antibodies – expansion of clones present from the start of treatment. The more things change, the more they stay the same (Plus ca change, plus ca ne change pas!). Translational Gastrointestinal Cancer, 28(1), 44-46. [More Information]

Kassahn, K., Holmes, O., Nones, K., Patch, A., Miller, D., Christ, A., Harliwong, I., Bruxner, T., Xu, Q., Anderson, M., Gill, A., et al (2013). Somatic Point Mutation Calling in Low Cellularity Tumors. PloS One, 8(11), 1-10. [More Information]

Gundara, J., Wang, F., Alvarado-Bachmann, R., Williams, N., Choi, J., Gananadha, S., Gill, A., Hugh, T., Samra, J. (2013). The clinical impact of early complete pancreatic head devascularisation during pancreatoduodenectomy. The American Journal Of Surgery, 206(4), 518-525. [More Information]

Westaway, D., Toon, C., Farzin, M., Sioson, L., Watson, N., Brady, P., Marshman, D., Mathur, M., Gill, A. (2013). The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma. Pathology, 45(6), 553-558. [More Information]

Lonborg, J., Ward, M., Gill, A., Grieve, S., Figtree, G. (2013). Utility of cardiac magnetic resonance in assessing right-sided heart failure in sarcoidosis. BMC Medical Imaging, 13(1), 1-5. [More Information]

Mazhar, J., Lawley, C., Gill, A., Grieve, S., Figtree, G. (2013). Visualizing pericardial inflammation as the cause of acute chest pain in a patient with a congenital pericardial cyst: the incremental diagnostic value of cardiac magnetic resonance. European Heart Journal, 34(19), 1413-1413. [More Information]

Chou, A., Toon, C., Pickett, J., Gill, A. (2013). von Hippel-Lindau syndrome. Frontiers of Hormone Research, 41, 30-49. [More Information]

Schulte, K., Gill, A., Barczynski, M., Karakas, E., Miyauchi, A., Knoefel, W., Lombardi, C., Talat, N., Diaz-Cano, S., Grant, C. (2012). Classification of Parathyroid Cancer. Annals of Surgical Oncology, 19(8), 2620-2628. [More Information]

Wang, F., Arianayagam, R., Gill, A., Puttaswamy, V., Neale, M., Gananadha, S., Hugh, T., Samra, J. (2012). Grafts for Mesenterico-Portal Vein Resections Can Be Avoided During Pancreatoduodenectomy. Journal of the American College of Surgeons, 215(4), 569-579. [More Information]

Paul, R., Elston, M., Gill, A., Marsh, D., Beer, I., Wolmarans, L., Conaglen, J., Meyer-Rochow, G. (2012). Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(2), 204-207. [More Information]

Prichard, R., Lee, J., Gill, A., Sywak, M., Fingleton, L., Robinson, B., Sidhu, S., Delbridge, L. (2012). Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. Thyroid, 22(2), 205-209. [More Information]

Biankin, A., Waddell, N., Kassahn, K., Gingras, M., Muthuswamy, L., Johns, A., Miller, D., Wilson, P., Patch, A., Wu, J., Gill, A., Kench, J., Pavlakis, N., Lam, V., Richardson, A., Samra, J., et al (2012). Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature, 491(7424), 399-405. [More Information]

Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2012). Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Annals of Surgical Oncology, 19(13), 4210-4216. [More Information]

Song, S., Nones, K., Miller, D., Harliwong, I., Kassahn, K., Pinese, M., Pajic, M., Gill, A., Johns, A., Anderson, M., et al (2012). qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles. PloS One, 7(9), 1-7. [More Information]

Gifford, A., Colebatch, A., Litkouhi, S., Hersch, F., Warzecha, W., Snook, K., Sywak, M., Gill, A. (2012). Remote frozen section examination of breast sentinel lymph nodes by telepathology. ANZ Journal of Surgery, 82(11), 803-808. [More Information]

Tactacan, C., Chang, D., Cowley, M., Humphrey, E., Wu, J., Gill, A., Chou, A., Nones, K., Grimmond, S., Sutherland, R., et al (2012). RON is not a prognostic marker for resectable pancreatic cancer. BMC Cancer, 12, 1-9. [More Information]

Xue, A., Chang, J., Chung, L., Samra, J., Hugh, T., Gill, A., Butterini, G., Baxter, R., Smith, R. (2012). Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. British Journal of Cancer, 107(11), 1883-1891. [More Information]

Gill, A. (2012). Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology, 44(4), 285-292. [More Information]

Chou, A., Chen, J., Clarkson, A., Samra, J., Clifton-Bligh, R., Hugh, T., Gill, A. (2012). Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression. Modern Pathology, 25(9), 1307-1313. [More Information]

Humphris, J., Chang, D., Johns, A., Scarlett, C., Pajic, M., Jones, M., Colvin, E., Nagrial, A., Chin, V., Chantrill, L., Samra, J., Gill, A., Kench, J., et al (2012). The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Annals of Oncology, 23(7), 1713-1722. [More Information]

Hahn, M., Dickson, K., Jackson, S., Clarkson, A., Gill, A., Marsh, D. (2012). The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination. Human Molecular Genetics, 21(3), 559-568. [More Information]

Zhang, J., Gill, A., Issacs, J., Atmore, B., Johns, A., Delbridge, L., Lai, R., McMullen, T. (2012). The Wnt/B-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer. Human Pathology, 43(7), 1044-1050. [More Information]

Bullock, M., O’Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]

Sanadanayake, N., Sinclair, J., Andreola, F., Chapman, M., Xue, A., Webster, G., Clarkson, A., Gill, A., Norton, I., Smith, R., et al (2011). A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. British Journal of Cancer, 105(9), 1370-1378. [More Information]

Paech, D., Weston, A., Pavlakis, N., Gill, A., Rajan, N., Barraclough, H., Fitzgerald, B., Van Kooten, M. (2011). A Systematic Review of the Interobserver Variability for Histology in the Differentiation between Squamous and Nonsquamos Non-small Cell Lung Cancer. Journal of Thoracic Oncology, 6(1), 55-63. [More Information]

Colebatch, A., Clarkson, A., Gill, A. (2011). Benign mesothelial cells as confounders when cytokeratin immunohistochemistry is used in sentinel lymph nodes. Human Pathology, 42(8), 1209-1210. [More Information]

Nguyen, N., Johns, A., Gill, A., Ring, N., Chang, D., Clarkson, A., Merrett, N., Kench, J., Colvin, E., Scarlett, C., et al (2011). Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas. Journal of Gastroenterology and Hepatology, 26(2), 267-274. [More Information]

Paik, J., Hall, G., Clarkson, A., Lee, L., Toon, C., Colebatch, A., Chou, A., Gill, A. (2011). Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian population. Human Pathology, 42(10), 1385-1390. [More Information]

Gill, A., Clarkson, A., Hall, G. (2011). Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma: Authors’ reply. Pathology, 43(1), 85-86. [More Information]

Galougahi, K., Harden, M., Maher, R., Gill, A., Bhindi, R., Grieve, S., Brady, P., Figtree, G. (2011). Incremental Diagnostic Value of Magnetic Resonance Imaging in the Characterization of a Cardiac Mass. Journal of the American College of Cardiology, 58(10), e19-e19. [More Information]

Abraham, D., Low, H., Messina, M., Jackson, N., Gill, A., Chou, A., Delbridge, L., Learoyd, D., Robinson, B., Sidhu, S., Sywak, M. (2011). Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment. Annals of Surgical Oncology, 18, 219-225. [More Information]

Abraham, D., Jackson, N., Gundara, J., Zhao, J., Gill, A., Delbridge, L., Robinson, B., Sidhu, S. (2011). MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets. Clinical Cancer Research, 17(14), 4772-4781. [More Information]

Gundara, J., Alvarado(-Bachman), R., Williams, N., Gananadha, S., Gill, A., Hugh, T., Samra, J. (2011). Multivisceral resection of pancreatic neuroendocrine tumours: A report of two cases. World Journal of Surgical Oncology, 9(93), 1-8. [More Information]

Samra, J., Bachmann, R., Choi, J., Gill, A., Neale, M., Puttaswamy, V., Bell, C., Norton, I., Cho, S., Blome, S., Maher, R., Gananadha, S., Hugh, T. (2011). One hundred and seventy-eight consecutive pancreatoduodenectomies without mortality: role of the multidisciplinary approach. Hepatobiliary & Pancreatic Diseases International, 10(4), 415-421. [More Information]

O’Neill, C., Chan, C., Symons, J., Learoyd, D., Sidhu, S., Delbridge, L., Gill, A., Sywak, M. (2011). Parathyroid Carcinoma Encountered After Minimally Invasive Focused Parathyroidectomy may not Require Further Radical Surgery. World Journal of Surgery, 35(1), 147-153. [More Information]

Brown, S., O’Neill, C., Suliburk, J., Sidhu, S., Sywak, M., Gill, A., Robinson, B., Delbridge, L. (2011). Parathyroid carcinoma: increasing incidence and changing presentation. ANZ Journal of Surgery, 81(7-8), 528-532. [More Information]

Gill, A., Pachter, N., Chou, A., Young, B., Clarkson, A., Tucker, K., Winship, I., Earls, P., Benn, D., Robinson, B., Clifton-Bligh, R., et al (2011). Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology. American Journal of Surgical Pathology, 35(10), 1578-1585. [More Information]

Zhang, J., Gill, A., Atmore, B., Johns, A., Delbridge, L., Lai, R., McMullen, T. (2011). Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer. International Journal of Clinical and Experimental Pathology, 4(4), 356-362. [More Information]

O’Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]

Hahn, M., Howell, V., Gill, A., Clarkson, A., Weaire-Buchanan, G., Robinson, B., Delbridge, L., Gimm, O., Schmitt, W., Teh, B., Marsh, D. (2010). CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocrine-Related Cancer, 17(1), 273-282. [More Information]

Pang, T., Ihre-Lundgren, C., Gill, A., McMullen, T., Sywak, M., Sidhu, S., Delbridge, L. (2010). Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms. Surgery, 148(3), 532-537. [More Information]

Stevenson, W., Hyland, C., Zhang, J., Morgan, P., Wilson, T., Gill, A., Hilton, A., Viney, E., Bahlo, M., Masters, S., et al (2010). Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice. Proceedings of the National Academy of Sciences of the United States of America, 107(38), 16625-16630. [More Information]

Hall, G., Clarkson, A., Shi, A., Langford, E., Leung, H., Eckstein, R., Gill, A. (2010). Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology, 42(5), 409-413. [More Information]

Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]

Gill, A., Benn, D., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G., Richardson, A., Sidhu, S., Robinson, B., Clifton-Bligh, R. (2010). Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Human Pathology, 41(6), 805-814. [More Information]

Meyer-Rochow, G., Jackson, N., Conaglen, J., Whittle, D., Kunnimalaiyaan, M., Chen, H., Westin, G., Sandgren, J., Stalberg, P., Khanafshar, E., Gill, A., Clifton-Bligh, R., Robinson, B., Benn, D., Sidhu, S., et al (2010). MicroRNA profiling of benign and malignant pheochromocytoma identifies novel diagnostic and therapeutic targets. Endocrine-Related Cancer, 17(3), 835-846. [More Information]

Grieve, S., Bhindi, R., Seow, J., Doyle, A., Turner, A., Tomka, J., Lay, W., Gill, A., Hunyor, S., Figtree, G. (2010). Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. Circulation. Heart Failure, 3(3), e5-e6. [More Information]

Aslani, A., Gill, A., Roach, P., Allen, B., Smith, R. (2010). Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple’s procedure. HPB, 12(5), 325-333. [More Information]

Losa, M., Mazza, E., Terrini, M., McCormack, A., Gill, A., Motta, M., Cangi, M., Talarico, A., Mortini, P., Reni, M. (2010). Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. European Journal of Endocrinology, 163(6), 843-851. [More Information]

Khasraw, M., Gill, A., Harrington, T., Pavlakis, N., Modlin, I. (2009). Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis. Journal of Clinical Gastroenterology, 43(9), 838-47. [More Information]

Chang, D., Johns, A., Merrett, N., Gill, A., Colvin, E., Scarlett, C., Nguyen, N., Leong, R., Cosman, P., Kelly, M., Kench, J., et al (2009). Margin Clearance and Outcome in Resected Pancreatic Cancer. Journal of Clinical Oncology, 27(17), 2855-2862. [More Information]

Soon, P., Tacon, L., Gill, A., Bambach, C., Sywak, M., Campbell, P., Yeh, M., Wong, S., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research, 15(24), 7684-7692. [More Information]

Alexander, S., Bourke, M., Williams, S., Bailey, A., Gill, A. (2008). Diagnosis of autoimmune pancreatitis with intraductal biliary biopsy and treatment of stricture with serial placement of multiple biliary stents. Gastrointestinal Endoscopy, 68(2), 396-9. [More Information]

Saxby, A., Gill, A., Samra, J. (2008). Education and imaging. Hepatobiliary and pancreatic: pseudotumor of the pancreas. Journal of Gastroenterology and Hepatology, 23(2), 340. [More Information]

Gill, A., Delbridge, L. (2008). Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World Journal of Surgery, 32(7), 1544-1545. [More Information]

Gill, A., Delbridge, L. (2008). Prevalence and Prognostic Significance of Poor Differentiation and Tall Cell Variant in Papillary Carcinoma in Japan. World Journal of Surgery, 32(7), 1544-1545. [More Information]

Kuo, S., Gananadha, S., Scarlett, C., Gill, A., Smith, R. (2008). Sporadic Pancreatic Polypeptide Secreting Tumors (PPomas) of the Pancreas. World Journal of Surgery, 32(8), 1815-1822. [More Information]

Moradi, P., Barakate, M., Gill, A., Farrow, G. (2007). Intussusception of the veriform appendix due to endometriosis presenting as acute appendicitis. ANZ Journal of Surgery, 77(9), 758-760. [More Information]

Meyer-Rochow, G., Alvarado, R., Sidhu, S., Delbridge, L., Gill, A. (2007). Letter 2: Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma (Br J Surg 2007; 94: 566-570). British Journal of Surgery, 94(8), 1044. [More Information]

Gill, A. (2006). Cannabis, pneumothorax and lung bullae. Journal of the Royal Society of Medicine, 99(4), 169-170; author reply 170. [More Information]

Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. (2006). Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone, 39(2), 369-376. [More Information]

Smith, R., Saxby, A., Nielsen, A., Scarlett, C., Clarkson, A., Morey, A., Gill, A. (2005). Assessment of HER-2 status in pancreatic adenocarcinoma: correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival. American Journal of Surgical Pathology, 29(9), 1125-1134. [More Information]

Gill, A. (2005). Bong lung: regular smokers of cannabis show relatively distinctive histologic changes that predispose to pneumothorax. The American Journal of Surgical Pathology, 29(7), 980-982. [More Information]

Nielsen, A., Scarlett, C., Samra, J., Gill, A., Li, Y., Allen, B., Smith, R. (2005). Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction. Journal of Gastroenterology and Hepatology, 20(2), 256-263. [More Information]

Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. The Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357. [More Information]

Nelson, A., Clifton-Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jueppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., et al (2003). Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. The Journal of Clinical Endocrinology and Metabolism, 88(9), 4088-4094. [More Information]

Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2002). Detection of the PAX8-PPARy Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. The Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.

For more information please contact:

Phone +61 2 9926 4399

Email [email protected]

Find out more ..